While both primary and metastatic tumors exhibited a full range of CDK8 distribution, the CDK8 and Ki67 (Figure 1(Bii)) immunoreactivities in the metastatic tissues were concentrated qualitatively in the tumoral and cystic regions. This evidence concerns the gene MKI67 and metastatic neoplasm.